Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Bissonnette

Showing results (151-160 of 222) with videos related to

Pageof 23
Sort By:
Journal of the American Academy of Dermatology|February 9, 2016
Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])Bruce E Strober, Robert Bissonnette, David Fiorentino, et al.
Dermatology and Therapy|September 12, 2021
Practical Management of Patients with Atopic Dermatitis on DupilumabKim A Papp, Chih-Ho Hong, M Perla Lansang, et al.
The Journal of Rheumatology|February 3, 2019
Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive SummaryKim A Papp, Boulos Haraoui, Deepali Kumar, et al.
Journal of Cutaneous Medicine and Surgery|November 23, 2018
Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive TherapiesKim A Papp, Boulos Haraoui, Deepali Kumar, et al.
Journal of the Canadian Association of Gastroenterology|October 17, 2019
Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive SummaryKim A Papp, Boulos Haraoui, Deepali Kumar, et al.
The Journal of Rheumatology|May 3, 2016
Dr. Roubille, et al replyCamille Roubille, Vincent Richer, Tara Starnino, et al.
Arthritis Care & Research|November 25, 2014
Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trialsStephanie Siu, Boulos Haraoui, Robert Bissonnette, et al.
Immunotherapy|February 27, 2025
ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitisEmma Guttman-Yassky, Eric Simpson, Robert Bissonnette, et al.
Allergy|September 30, 2022
Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseasesAna B Pavel, Ester Del Duca, Julia Cheng, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 15, 2022
Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic DermatitisKristian Reich, Peter A Lio, Robert Bissonnette, et al.
Pageof 23

Showing results (151-160 of 222) with videos related to

Sort By:
Pageof 23
Journal of the American Academy of Dermatology|February 9, 2016
Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])Bruce E Strober, Robert Bissonnette, David Fiorentino, et al.
Dermatology and Therapy|September 12, 2021
Practical Management of Patients with Atopic Dermatitis on DupilumabKim A Papp, Chih-Ho Hong, M Perla Lansang, et al.
The Journal of Rheumatology|February 3, 2019
Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive SummaryKim A Papp, Boulos Haraoui, Deepali Kumar, et al.
Journal of Cutaneous Medicine and Surgery|November 23, 2018
Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive TherapiesKim A Papp, Boulos Haraoui, Deepali Kumar, et al.
Journal of the Canadian Association of Gastroenterology|October 17, 2019
Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive SummaryKim A Papp, Boulos Haraoui, Deepali Kumar, et al.
The Journal of Rheumatology|May 3, 2016
Dr. Roubille, et al replyCamille Roubille, Vincent Richer, Tara Starnino, et al.
Arthritis Care & Research|November 25, 2014
Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trialsStephanie Siu, Boulos Haraoui, Robert Bissonnette, et al.
Immunotherapy|February 27, 2025
ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitisEmma Guttman-Yassky, Eric Simpson, Robert Bissonnette, et al.
Allergy|September 30, 2022
Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseasesAna B Pavel, Ester Del Duca, Julia Cheng, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 15, 2022
Magnitude and Time Course of Response to Abrocitinib for Moderate-to-Severe Atopic DermatitisKristian Reich, Peter A Lio, Robert Bissonnette, et al.
Pageof 23